Research Update for HER2-Positive MBC | 2022-2023 EMBRACE MBC Virtual Forum Series

Philip Poorvu, MD; Adrienne Waks, MD; and Christine Agius, NP, discuss advances in research and treatment for patients with HER2-positive metastatic breast cancer.


October 7, 2022

Created by


Related Presenters

Philip Poorvu, MD Poorvu, MD

Philip Poorvu, MD Poorvu, MD

Instructor in Medicine, Harvard Medical School

Dr. Poorvu received his medical degree from the University of Pennsylvania in 2012 and went on to complete his residency in internal medicine at the Brigham and Women's Hospital.

View full profile

Adrienne Waks, MD

Adrienne Waks, MD

Associate Director, Clinical Research

Dr. Waks received her undergraduate degree from Princeton University in 2006 and her MD degree from Harvard Medical School in 2011.

View full profile